Atea Pharmaceuticals has won a credit deal worth up to $200 million from Hercules Capital, starting with $65 million.

HTGC · Hercules Capital

The AI's read

The loan gives Hercules a chance to earn interest from a new borrower. Atea is still developing treatments, and later funding depends on milestones, so the full amount is not assured. The initial funding and lending opportunity make the deal favorable for Hercules.